Thrivent Financial for Lutherans
Position in NBIX — Neurocrine Biosciences Inc
CIK 314984
Minneapolis, MN
Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$50,106,435
+$37,395,502 QoQ
Shares Held
297,297
+208.1% QoQ
Ownership
0.292%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#62
of 768 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Thrivent Financial for Lutherans holds $170,891,735 across 22 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (29.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
128,626 | $69,693,424 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
297,297 | $50,106,435 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
746,855 | $18,380,101 | |
| 4 | ALKS |
Alkermes plc.
|
109,450 | $5,735,180 | |
| 5 | LQDA |
Liquidia Corp
|
46,133 | $3,678,184 | |
| 6 | VTRS |
Viatris Inc
|
230,572 | $3,661,482 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
80,062 | $3,284,943 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
113,125 | $1,958,193 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,106,435 | 297,297 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $12,710,933 | 96,485 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $12,809,801 | 90,318 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $80,267,178 | 571,785 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $98,955,611 | 787,299 | Shares | Sole | 2025-08-26 | |
| 2025-03-31 | $97,196,938 | 878,815 | Shares | Sole | 2025-08-26 | |
| 2024-12-31 | $100,705,877 | 737,772 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $2,972,906 | 25,802 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $6,412,255 | 46,577 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,439,173 | 24,936 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,234,049 | 24,545 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,750,737 | 24,451 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,374,945 | 25,185 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,580,097 | 25,490 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $3,615,687 | 30,272 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $2,688,493 | 25,313 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,444,311 | 25,075 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $2,324,062 | 24,790 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,130,442 | 25,014 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $2,372,717 | 24,739 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,442,634 | 25,099 | Shares | Sole | 2021-09-24 | |
| 2021-03-31 | $2,428,818 | 24,975 | Shares | Sole | 2021-05-17 | |
| 2020-09-30 | $3,425,699 | 35,625 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $27,819,050 | 228,025 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $19,642,522 | 226,950 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||